✦ LIBER ✦

Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function

✍ Scribed by Patel, Nileshkumar J.; Hoosien, Michael; Deshmukh, Abhishek; Badheka, Apurva O.; Grover, Peeyush M.; Shah, Neeraj; Singh, Vikas; Mehta, Kathan; Chothani, Ankit; Savani, Ghanshyambhai T.; Arora, Shilpkumar; Bhalara, Vipulkumar; Patel, Nilay; Khalpada, Dhaval; Rathod, Ankit; Vazzana, Thomas J.; Lafferty, James; Viles-Gonzalez, Juan F.; Mitrani, Raul D.

Book ID: 121814498
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 173 KB
Volume: 169
Category: Article
ISSN: 0167-5273
DOI: 10.1016/j.ijcard.2013.10.040

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of dofetilide in the treatment

Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function. A danish investigation of arrhythmia and mortality on dofetilide (diamond) substudy

✍ O.D Pedersen; H Bagger; N Keller 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Determinants of All-Cause Mortality in D

Determinants of All-Cause Mortality in Different Age Groups in Patients With Severe Systolic Left Ventricular Dysfunction Receiving an Implantable Cardioverter Defibrillator (from the Italian ClinicalService Multicenter Observational Project)

✍ Fumagalli, Stefano; Gasparini, Maurizio; Landolina, Maurizio; Lunati, Maurizio; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 383 KB